| Literature DB >> 23837557 |
Muhammad Ibrahim1, Tahir Farooq, Nusrat Hussain, Amjad Hussain, Tahsin Gulzar, Iqbal Hussain, Muhammad Sajid Akash, Fouzia Sultana Rehmani.
Abstract
BACKGROUND: Alzheimer's disease (AD) is characterized by a progressive memory loss that leads to a profound emotional disturbance in later stages. As no safe and effective drug is yet available for the treatment of AD, secondary metabolites from plants may be instrumental in meeting this challenge. Keeping in view this point we evaluated sesquiterpenes of medicinal plant Amberboa ramosa for their cholinesterase inhibitory activity.Entities:
Year: 2013 PMID: 23837557 PMCID: PMC3718625 DOI: 10.1186/1752-153X-7-116
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Figure 1Structures of compounds 1–4.
H- and C-NMR for compound 68; CDOD soln.; δ in ppm, in Hz
| 1 | 2.80 ddd (9.0, 8.5, 8.0) | 53.0 | CH |
| 2 | 2.35 dd (15.5, 5.0) | 34.0 | CH2 |
| 2.24 dd (9.0, 8.0) | |||
| 3 | 5.40 brd s | 126.8 | CH |
| 4 | - | 144.0 | C |
| 5 | 2.90 dd (9.0, 8.8) | 55.0 | CH |
| 6 | 4.25 dd (10.0, 8.3) | 82.3 | CH |
| 7 | 2.85 ddd (10.0, 9.5, 8.3) | 52.3 | CH |
| 8 | 5.07 ddd (8.3, 6.0, 5.5) | 75.4 | CH |
| 9 | 1.86 dd (12.3, 5.5) | 42.8 | CH2 |
| 2.38 dd (12.3, 6.0) | |||
| 10 | - | 81.1 | C |
| 11 | 2.50 dq (11.0, 5.8) | 42.1 | CH |
| 12 | - | 172.1 | C |
| 13 | 1.24 d (6.9) | 15.7 | CH3 |
| 14 | 1.27 s | 26.1 | CH3 |
| 15 | 1.79 s | 17.7 | CH3 |
| 16 | - | 181.0 | C |
| 17 | 2.05 s | 21.3 | CH3 |
| 18 | 3.63-3.65 m | 73.86 | CH |
| 19 | 3.59 d | 64.4 | CH2 |
| 3.56 d | |||
| 20 | 3.52 d | 64.4 | CH2 |
| 3.48 d |
a) Recorded at 400 MHz; b) Recorded at 100 MHz.
Figure 2Important COSY and HMBC correlations.
Figure 3Important NOESY correlations.
anticholinesterase activities of compounds 1–4
| | | ||
|---|---|---|---|
| 1 | Amberbin C ( | 1.1 ± 0.08 | 17.9 ± 0.05 |
| 2 | Amberin ( | 17.5 ± 0.01 | 2.7 ± 0.02 |
| 3 | Amberbin A ( | 8.6 ± 0.15 | 4.8 ± 0.15 |
| 4 | Amberbin B ( | 0.91 ± 0.015 | 2.5 ± 0.15 |
| 5 | Galanthamineb | 0.5 ± 0.01 | 8.2 ± 0.02 |
| 6 | Eserineb | 0.04 ± 0.0001 | 0.82 ± 0.001 |
a Standard error of the mean of five assays; b positive control used in the assays.